Company / Operating Cash Flow per Share
Cartesian Therapeutics, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.92
FY2025
5-year range
-$9.48 / $0.28
FY2021-FY2025
Trend
+90.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-0.92.
Based on SEC 10-K filings.
-0.92 in FY2025.
Declined from $-0.39 to $-0.92 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 90.3% year-over-year.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.92 | +90.3% |
| FY2024 | -$9.48 | -2302.4% |
| FY2023 | -$0.39 | -239.8% |
| FY2022 | $0.28 | +159.3% |
| FY2021 | -$0.48 | +30.6% |
| FY2020 | -$0.69 | +70.4% |
| FY2019 | -$2.32 | +60.3% |
| FY2016 | -$5.84 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026